Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Synergistic Modulation of Inflammatory but not Metabolic Effects of High-Fat Feeding by CCR2 and CX3CR1

Zhang H., Hinkle CC., O'Neill SM., Shi J., Caughey J., Lynch E.

Animal Study on Type 2 Diabetes, published in Obesity (Silver Spring) (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Obesity (Silver Spring) (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28650582
PMCID
PMC5610963
DOI
10.1002/oby.21900
Citations
8

Abstract (original English)

Objective The purpose of the study was to explore the impact of dual targeting of C-C motif chemokine receptor-2 (CCR2) and fractalkine receptor (CX3CR1) on the metabolic and inflammatory consequences of obesity induced by a high-fat diet (HFD). Methods C57BL/6J wild-type, Cx3cr1 -/- , Ccr2 -/- , and Cx3cr1 -/- Ccr2 -/- double-knockout male and female mice were fed a 45% HFD for up to 25 weeks starting at 12 weeks of age. Results All groups gained weight at a similar rate and developed a similar degree of adiposity, hyperglycemia, glucose intolerance, and impairment of insulin sensitivity in response to HFD. As expected, the circulating monocyte count was decreased in Ccr2 -/- and Cx3cr1 -/- Ccr2 -/- mice but not in Cx3cr1 -/- mice. Flow cytometric analysis of perigonadal adipose tissue of male, but not female, mice revealed trends to lower CD11c+MGL1- M1-like macrophages and higher CD11c-MGL1+ M2-like macrophages as a percentage of CD45+F4/80+CD11b+ macrophages in Cx3cr1 -/- Ccr2 -/- mice versus wild-type mice, suggesting reduced adipose tissue macrophage activation. In contrast, single knockout of Ccr2 or Cx3cr1 did not differ in their adipose macrophage phenotypes. Conclusions Although CCR2 and CX3CR1 may synergistically impact inflammatory phenotypes, their joint deficiency did not influence the metabolic effects of a 45% HFD-induced obesity in these model conditions.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
MacrophagesAnimalsMice, Inbred C57BLMice, KnockoutMiceGlucose IntoleranceInsulin ResistanceObesityInflammationWeight Gain

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research